![]() |
市場調査レポート
商品コード
1319151
ニードルカウンターの世界市場-2023年~2030年Global Needle Counters Market - 2023-2030 |
||||||
カスタマイズ可能
適宜更新あり
|
ニードルカウンターの世界市場-2023年~2030年 |
出版日: 2023年07月31日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
|
ニードルカウンターの世界市場は、2022年に21億米ドルに達し、2030年には30億米ドルに達し、有利な成長が予測されています。世界のニードルカウンター市場は、予測期間中(2023-2030年)にCAGR 4.7%を示すと予測されています。
ニードルカウンターは、手術環境において不可欠な機器であり、患者の安全性の向上、医療ミスの削減、ワークフロー効率の改善、規制遵守の確保、説明責任と品質管理の促進に役立っています。ヘルスケア従事者は、ニードルカウンターを採用することで、全体的な手術経験を改善し、リスクを低減し、患者の転帰を改善することができます。
病院環境では、ニードルカウンターにより説明責任と品質管理が向上します。 医療従事者は、これらの機器を使用して標準化された針管理方法を構築し、すべての針が集計されていることを保証し、人為的ミスの可能性を排除することができます。さらに、慢性疾患の増加、老人人口の増加、市場参入企業による先進的な新製品のイントロダクションが、ニードルカウンター市場規模を押し上げています。
高齢化社会では、外科手術を含むより多くの医療介入が頻繁に必要とされます。高齢になると、人工股関節置換術、心臓治療、腫瘍切除術など、手術を必要とする健康上の問題を抱えるようになります。高齢者人口が増加するにつれ、外科手術の需要も増加し、これらの患者の安全と幸福を保証するためのニードルカウンターの需要も増加します。視力の低下、聴覚障害、記憶障害など、感覚や認知の異常が高齢者人口に発生する可能性があります。
例えば、Eurostatによると、2022年1月のEU人口は4億4,670万人と推定され、そのうち65歳以上の高齢者は21.1%で、前年比0.3ポイント(pp)の増加、10年前と比較すると3.1ppの増加となっています。さらに、国連(UN)の新しい報告書によると、世界全体で65歳以上の高齢者の数は、今後30年間で2倍に増加すると予想されています。老人人口は2050年には16億人に達し、世界人口の16%を超えると予想されています。このように老年人口が増加することで、市場の成長が促進されます。
慢性疾患は、継続的な医療モニタリングと介入を必要とする場合があります。外科的処置、生検、輸液、その他の侵襲的処置は介入の一例です。糖尿病、心血管疾患、がんなどの慢性疾患の世界の有病率は増加しています。その結果、これらの処置で使用される針の正確な追跡と回収を保証するために、針カウンタの需要が高まっています。
このように心臓血管外科手術の増加は、あらゆる手技のためのニードルカウンターの市場成長を促進するのに役立っています。例えば、NLMによると、CABG手術は毎年40万件近く行われており、最も一般的な主要外科手術となっています。しかし、内科的治療や経皮的冠動脈インターベンション(PCI)などの別の選択肢がより一般的になったため、手術動向は変化しています。この活動は、冠動脈バイパス手術の適応を示し、CAD患者の管理における専門職間チームの重要性を強調しています。その結果、ニードルカウンターの市場成長率は上昇します。
しかし、ニードルカウンターは購入にもメンテナンスにもコストがかかります。このコストは、財政に制約のあるヘルスケア施設、特に小規模のクリニックやリソースの限られた施設にとっては高すぎるかもしれないです。ヘルスケア従事者は、針計数システムの適切な使用方法についてトレーニングを受ける必要があります。正確な計数を確実に行い、エラーを最小限に抑えるためには、技術とその仕組みに精通していることが極めて重要です。トレーニングには、より多くの時間とリソースが必要になる可能性があります。その結果、前述の要因が市場拡大を阻害します。
COVID-19の発生は外科手術に世界的に大きな影響を及ぼしています。COVID-19患者のためにリソースと病院のキャパシティを集中させるため、多くの病院やヘルスケア・システムは緊急でない手術や選択的手術を延期またはキャンセルしました。これはCOVID-19感染のリスクを減らし、個人防護具(PPE)を節約し、人と資源を最も必要な場所に再配分するためです。COVID-19が手術に与える影響は、パンデミックの深刻度、ヘルスケア資源の利用可能性、ウイルスの理解の進展によって異なります。
The Global Needle Counters market reached US$ 2.1 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 3.0 billion by 2030. The global needle counters market is expected to exhibita CAGR of 4.7% during the forecast period (2023-2030).
Needle counters are essential equipment in surgical settings, helping to improve patient safety, reduce medical errors, improve workflow efficiency, ensure regulatory compliance, and promote accountability and quality control. Healthcare workers can improve the overall surgical experience, reduce risks, and improve patient outcomes by employing needle counters.
In hospital settings, needle counters improve accountability and quality control. Medical personnel can use these devices to create a standardised needle management method, guaranteeing that every needle is tallied and eliminating the chance of human mistake. Furthermore, increasing incidences of chronic diseases, a growing geriatric population, and the introduction of new advanced products by market players are elevating needle counters market size.
More medical interventions, including surgical operations, are frequently required in the aged population. As people get older, they may acquire health problems that demand surgery, such as hip replacements, heart treatments, or tumour excision. As the senior population grows, so does the demand for surgical operations, which increases the demand for needle counters to assure the safety and well-being of these patients. Sensory and cognitive abnormalities, such as diminished eyesight, hearing difficulties, or memory issues, may occur in the aged population.
For instance, according to Eurostat, the EU population in January 2022, was estimated to be 446.7 million, out of which 21.1% were Older individuals aged 65 or over indicating an increase of 0.3 percentage points (pp) to the previous year and an increase of 3.1 pp compared with a decade earlier. In addition, according to a new report by the United Nations (UN), the number of individuals aged 65 years or above globally is anticipated to increase two folds in the next 30 years. The geriatric population is expected to attain 1.6 billion in 2050, making up over 16% of the world population. By thus increasing the geriatric population will drive the market growth.
Chronic diseases may necessitate continuing medical monitoring and intervention. Surgical procedures, biopsies, infusions, and other invasive procedures are examples of interventions. The global prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer is increasing. As a result, needle counters are in high demand to ensure the precise tracking and retrieval of needles used in these procedures.
Thus rise of cardiovascular surgeries helps to drive the market growth in needle counters for every procedure. For instance, according to NLM, almost 400,000 CABG operations are performed each year, making it the most common major surgical surgery, however surgical trends have shifted as alternate choices such as medical treatment and percutaneous coronary intervention (PCI) have become more popular. This activity demonstrates the indications for coronary artery bypass surgery and emphasises the significance of the interprofessional team in the management of CAD patients. As a result, market growth of needle counters rises.
However, needle counters can be costly for both purchasing and maintaining. This cost may be too expensive for healthcare facilities with restricted finances, particularly smaller clinics or settings with limited resources. Healthcare practitioners must be trained in the proper use of the needle counting system. It is critical to be familiar with the technology and how it works in order to ensure precise counting and minimise errors. Training may necessitate more time and resources. As a result, the aforementioned factors impede market expansion.
The COVID-19 outbreak has had a massive global influence on surgical procedures. In order to concentrate resources and hospital capacity for COVID-19 patients, many hospitals and healthcare systems have postponed or cancelled non-urgent or elective surgeries. This was done to reduce the risk of COVID-19 transmission, conserve personal protective equipment (PPE), and reallocate people and resources to where they are most required. The impact of COVID-19 on surgeries will vary depending on the severity of the pandemic, the availability of healthcare resources, and the virus's evolving understanding.
The global needle counters market is segmented based on excersise type, end user and region.
Foam needle counters, also known as foam needle detection systems or foam needle detectors, are medical devices designed to detect and prevent the inadvertent retention of surgical needles in patients in surgical and healthcare settings. The significance of foam needle counters stems from their capacity to improve patient safety by lowering the possibility of retained surgical needles, which can result in catastrophic consequences.
Patients can suffer considerable injury from retained surgical needles, including infections, internal injuries, and the need for additional surgical treatments. By adding an extra layer of protection during surgical procedures, foam needle counters help to prevent these undesirable outcomes.
Additionally, foam needle counters serve an important role in increasing patient safety, quality assurance, workflow efficiency, and compliance with healthcare regulations. They help to reduce the risk of retained surgical needles and the accompanying problems by providing an automated and reliable technique of needle detection.
North America region is expected to serve a large share of the market owing to the increasing patient population as a result of rise in the geriatric population and the increasing prevalence of chronic diseases, which leads to a large number of surgical procedures, high prevalence of HAIs, the existence of advanced healthcare infrastructure in the US and Canada, the implementation of favorable government initiatives and stringent regulations on needle counters, and the presence of key players in this region.
For instance, according to OASH, in hospitals alone, one in every 31 hospitalised patients has at least one HAI at any given moment, resulting in about 680,000 infections and billions of dollars in excess health care expenses in the United States each year. Despite tremendous success in preventing various HAI types during the previous decade, much more effort remains to be done. As a result, the rise of HAI contributes to the growth of the region.
The major global players in the needle counters market: STERIS, NewGen Surgical, Boen Healthcare, Medical Action Industries, Xodus Medical, Austramedex, ArcRoyal, Medtronic, Cardinal Health, Advanced Medical Innovation Inc among others.
The global Needle Counters market report would provide approximately 53 tables, 54 figures and 195 Pages.
LIST NOT EXHAUSTIVE